Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Basics of Compounding: Basics of Compounding with Potency Designated Ingredients

Author(s):  Allen Loyd V Jr

Issue:  Jan/Feb 2011 - Volume 15, Number 1
View All Articles in Issue

Page(s):  56-61

Basics of Compounding: Basics of Compounding with Potency Designated Ingredients Page 1
Basics of Compounding: Basics of Compounding with Potency Designated Ingredients Page 2
Basics of Compounding: Basics of Compounding with Potency Designated Ingredients Page 3
Basics of Compounding: Basics of Compounding with Potency Designated Ingredients Page 4
Basics of Compounding: Basics of Compounding with Potency Designated Ingredients Page 5
Basics of Compounding: Basics of Compounding with Potency Designated Ingredients Page 6

Download in electronic PDF format for $65

Abstract:  Pharmacists involved in compounding must consider a number of factors when determining the actual quantity of an active ingredient to use for a compounded prescription. Many drug substances do not consist of 100% drug or chemical, and adjustments must be made to obtain the required amount of active drug (active pharmaceutical ingredient). This article covers the topic of compounding with “potency-designated” drugs.

Related Keywords: Loyd V. Allen Jr., PhD, RPh, bulk substance potency, biologic agents, biological agents, active pharmaceutical ingredients, drug potency designations, drug activity

Related Categories: SUPPORT

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312

Basics of Compounding: Basics of Compounding with Potency Designated Ingredients
Allen Loyd V Jr
Jan/Feb 2011
Pg. 56-61

Compounding for the Effects of Weapons of Mass Destruction
Sammarco Domenic A
Jan/Feb 2003
Pg. 10-15

View Sample
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA
Cabaleiro Joe
Sep/Oct 2021
Pg. 358-362

Basics of Sterile Compounding: Excipients Used in Injections
Akers Michael J
Jul/Aug 2017
Pg. 301-308

Hygrometers and Thermohygrometers: Environmental Monitoring Ensures the Potency and Stability of Compounding Agents
Allen Loyd V Jr
, McKenzie Robert, Ainsworth Ron, Kastango Eric S, Kaestner Rick, Rebelo Andre, Burnside Paul, Schultz Gerald
Jul/Aug 2010
Pg. 284-300

U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Miller David G
Jul/Aug 2015
Pg. 303-305

Compounding with Biotechnology Products, Part 1: General Considerations
Allen Loyd V Jr
Sep/Oct 2022
Pg. 385-395

Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Allen Loyd V Jr
Jul/Aug 2016
Pg. 351

View Sample
Particle Measuring Systems - USP <797> Environmental Monitoring Solutions